Compass Therapeutics stock price target maintained at $6 by Stifel - Investing.com UK

BestAIBroker analysis

• Finance-aware sentiment: neutral (+0.00 on a -1 to +1 scale).
• Event classification: OTHER.
• Market importance score: 28/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
• Symbols referenced: CMPX, UK.